ArticleCellular oncology (Dordrecht, Netherlands)2021

CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma.

Gang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.